The Gaming of Pharmaceutical Patents
Preprint
- 1 January 2003
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
Paragraph IV of the Hatch-Waxman Act provides a mechanism for the litigation of pharmaceutical patent infringement disputes. Many of these cases have been settlKeywords
This publication has 16 references indexed in Scilit:
- Mother May Ithe minnesota review, 2013
- Are Settlements of Patent Disputes Illegal per Se?The Antitrust Bulletin, 2002
- Stopping Above-Cost Predatory PricingThe Yale Law Journal, 2002
- The Shifting Functional Balance Of Patents And Drug RegulationHealth Affairs, 2001
- Generic Entry and the Pricing of PharmaceuticalsJournal of Economics & Management Strategy, 1997
- JunePublished by SAGE Publications ,1994
- Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical IndustryBrookings Papers on Economic Activity. Microeconomics, 1991
- Longer patents for lower imitation barriers: The 1984 Drug ActJournal of Product Innovation Management, 1987
- Dissolving a Partnership EfficientlyEconometrica, 1987
- Multimarket Oligopoly: Strategic Substitutes and ComplementsJournal of Political Economy, 1985